Novartis to pay $30 million to health plans, consumers over Exforge antitrust claims
By Brendan Pierson (Reuters) – Swiss drugmaker Novartis AG has
novartis
Novartis names Firmenich CEO as chairman designate of Sandoz
ZURICH (Reuters) – Novartis on Monday announced the appointment of
Novartis weighs sale of ophthalmology, respiratory units – Bloomberg
(Reuters) -Swiss drugmaker Novartis AG is considering to sell its
Novartis to cut its Irish workforce by up to 25%
DUBLIN (Reuters) – Novartis said on Thursday that it would
Novartis plans to close a Sandoz plant in North Carolina
ZURICH (Reuters) – Pharmaceuticals company Novartis plans to close a
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Novartis AG – NVS
NEW YORK, July 13, 2022 — Pomerantz LLP is investigating
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Novartis AG – NVS
NEW YORK, July 5, 2022 — Pomerantz LLP is investigating
Novartis wins U.S. approval for targeted cancer drug combination
FRANKFURT – A targeted oral drug combination by Novartis won
Novartis drug combo shows promise in childhood brain cancer
FRANKFURT – An oral drug combination by Swiss pharmaceuticals company
Novartis to cut thousands of jobs in global revamp – paper
ZURICH – Swiss drugmaker Novartis will cut thousands of jobs
Novartis suspends some business activities in Russia
GENEVA – Swiss drugmaker Novartis said on Tuesday it was
Blackstone, Carlyle consider joint bid for Novartis generics unit – Bloomberg News
– Private equity firms Blackstone Inc and Carlyle Group Inc